On Monday, Cognition Therapeutics Inc (NASDAQ: CGTX) opened higher 10.07% from the last session, before settling in for the closing price of $1.39. Price fluctuations for CGTX have ranged from $0.22 to $3.83 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -16.44%. Company’s average yearly earnings per share was noted 54.65% at the time writing. With a float of $80.15 million, this company’s outstanding shares have now reached $88.27 million.
Cognition Therapeutics Inc (CGTX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cognition Therapeutics Inc is 9.20%, while institutional ownership is 17.42%. The most recent insider transaction that took place on Jan 31 ’25, was worth 30,001. In this transaction CEO & President of this company bought 38,851 shares at a rate of $0.77, taking the stock ownership to the 38,851 shares.
Cognition Therapeutics Inc (CGTX) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.17 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.15) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to -16.44% drop over the previous five years of trading.
Cognition Therapeutics Inc (NASDAQ: CGTX) Trading Performance Indicators
Check out the current performance indicators for Cognition Therapeutics Inc (CGTX). In the past quarter, the stock posted a quick ratio of 6.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.47, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of Cognition Therapeutics Inc (CGTX)
The latest stats from [Cognition Therapeutics Inc, CGTX] show that its last 5-days average volume of 1.04 million was inferior to 4.23 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 22.56%.
During the past 100 days, Cognition Therapeutics Inc’s (CGTX) raw stochastic average was set at 32.34%, which indicates a significant decrease from 43.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1451 in the past 14 days, which was lower than the 0.1980 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5976, while its 200-day Moving Average is $0.9484. Now, the first resistance to watch is $1.5933. This is followed by the second major resistance level at $1.6567. The third major resistance level sits at $1.7633. If the price goes on to break the first support level at $1.4233, it is likely to go to the next support level at $1.3167. The third support level lies at $1.2533 if the price breaches the second support level.
Cognition Therapeutics Inc (NASDAQ: CGTX) Key Stats
There are currently 88,274K shares outstanding in the company with a market cap of 135.06 million. Presently, the company’s annual sales total 0 K according to its annual income of -33,970 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -4,930 K.
